MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Lung Cancer

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Non-Small Cell Lung Cancer with PD-L1 Expression
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Pembrolizumab
  • Number of Patients: 1388
  • Published —
This study investigated the association between obesity and clinical outcomes in patients undergoing first-line pembrolizumab therapy for their non-small cell lung cancer with PD-L1 expression greater than 50%.
Latest Advance
Study
  • Condition: Unresectable Stage III Non-Small Cell Lung Cancer
  • Journal: Technology in cancer research & treatment
  • Treatment Used: Radiotherapy and Induction Chemotherapy
  • Number of Patients: 227
  • Published —
This study investigated the incidence of toxicity in patients undergoing radiotherapy and induction chemotherapy to treat patients with unresectable stage III non-small cell lung cancer.
Latest Advance
Study
  • Condition: Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
  • Journal: JAMA network open
  • Treatment Used: First-Line Treatments
  • Number of Patients: 4838
  • Published —
This study compared first-line treatments for patients with extensive-stage (has spread far from the original tumor) small cell lung cancer (disease in which cells in the lung begin growing out of control; ES-SCLC).
Latest Advance
Study
  • Condition: Large cell neuroendocrine carcinoma (LCNEC) of Lungs
  • Journal: Annals of palliative medicine
  • Treatment Used: Surgery, Radiotherapy, Chemotherapy, and Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 64-year-old male smoker diagnosed with pulmonary large cell neuroendocrine carcinoma (LCNEC) treated with thoracoscopic radical surgery, postoperative chemotherapy with a double-drug regimen holding platinum, and then, bevacizumab, paclitaxel, and the PD-L1 checkpoint inhibitor nivolumab.
Latest Advance
Study
  • Condition: Patients with Lung Cancer with Limited Brain Metastases (LBM)
  • Journal: Annals of palliative medicine
  • Treatment Used: Focal Conformal Fractionated Radiotherapy (FCFRT) vs. Radiosurgery (RS)
  • Number of Patients: 23
  • Published —
This study reported experience with an alternative strategy (focal conformal fractionated radiotherapy; FCFRT) for patients with lung cancer (LC) with limited brain metastases (LBM).
Latest Advance
Study
  • Condition: Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
  • Journal: Cell
  • Treatment Used: Personalized Neoantigen Therapy Plus Anti-PD-1
  • Number of Patients: 82
  • Published —
This study reported results for a personalized neoantigen-based vaccine, NEO-PV-01, in combination with PD-1 blockade in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer.
Latest Advance
Study
  • Condition: Advanced Solid Tumors
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: AMG 820 with Pembrolizumab
  • Number of Patients: 116
  • Published —
This study tested the safety and efficacy of using AMG 820 with pembrolizumab to treat patients with advanced soild tumors.
Latest Advance
Study
  • Condition: Main Bronchus Fistula
  • Journal: Khirurgiia
  • Treatment Used: Transsternal Occlusion
  • Number of Patients: 146
  • Published —
This study summarized experience with transsternal occlusion of main bronchus fistula.
Latest Advance
Study
  • Condition: Non-small Cell Lung Cancer
  • Journal: Khirurgiia
  • Treatment Used: Surgery
  • Number of Patients: 190
  • Published —
In this study, researchers evaluated the short-term outcomes of undergoing surgery for the treatment of non-small cell lung cancer in the elderly.
Latest Advance
Study
  • Condition: Lung Cancer
  • Journal: Cellular and molecular biology (Noisy-le-Grand, France)
  • Treatment Used: Rapamycin
  • Number of Patients: 0
  • Published —
The study researched the outcomes of rapamycin for treating lung cancer.
Latest Advance
Study
  • Condition: Lung Cancer
  • Journal: Cellular and molecular biology (Noisy-le-Grand, France)
  • Treatment Used: Sevoflurane Inhalation Anesthesia with Lobectomy
  • Number of Patients: 168
  • Published —
This study tested the safety and efficacy of using sevoflurane inhalation anesthesia for elderly patients undergoing lobectomy for their lung cancer.
Latest Advance
Study
  • Condition: Advanced Stage Adenocarcinoma of the Lung
  • Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • Treatment Used: Pemetrexed
  • Number of Patients: 0
  • Published —
This study evaluated the prognostic role of systemic immune-inflammation index (SII) in patients who received platin-pemetrexed combination therapy and/or maintenance pemetrexed therapy for the treatment of advanced stage adenocarcinoma of the lung.
Showing 1–12 of 1,629 Latest Research
Next